thioctic acid has been researched along with Hematologic Malignancies in 1 studies
Thioctic Acid: An octanoic acid bridged with two sulfurs so that it is sometimes also called a pentanoic acid in some naming schemes. It is biosynthesized by cleavage of LINOLEIC ACID and is a coenzyme of oxoglutarate dehydrogenase (KETOGLUTARATE DEHYDROGENASE COMPLEX). It is used in DIETARY SUPPLEMENTS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhong, Y | 1 |
| Meng, F | 1 |
| Deng, C | 1 |
| Mao, X | 1 |
| Zhong, Z | 1 |
1 other study available for thioctic acid and Hematologic Malignancies
| Article | Year |
|---|---|
Targeted inhibition of human hematological cancers in vivo by doxorubicin encapsulated in smart lipoic acid-crosslinked hyaluronic acid nanoparticles.
Topics: Animals; Cell Line, Tumor; Doxorubicin; Hematologic Neoplasms; Humans; Hyaluronic Acid; Mice; Mice, | 2017 |